About MITRASSIST
Founded in 2017, MITRASSIST LIFESCIENCES LIMITED has been serving as a leading global platform company for innovative cardiovascular medical devices, focusing on providing advanced diagnostic and therapeutic solutions for cardiovascular patients.
As a pioneer in the cardiovascular field, MITRASSIST LIFESCIENCES LIMITED continues to promote technological innovation, and its product line covers a wide range of scenarios such as diagnosis, treatment, surgery, prognosis, etc., to provide cardiovascular patients with systematic, multi-disease diagnostic and treatment solutions.
The company takes comprehensive cardiovascular inclusive diagnosis and treatment as a pioneer, and its heart failure, structural heart and drug balloon products comprehensively cover the two major departments of cardiology and cardiac surgery, realizing a high degree of focus and synergy across the chain.

Looking Ahead To The Future

MITRASSIST LIFESCIENCES LIMITED will continue to work together with global partners to promote the development of cardiovascular medicine and make greater contributions to human health.

Excellent Products of MITRASSIST
MITRASSIST LIFESCIENCES LIMITED is patient-centered and driven by technological innovation, and is committed to providing global cardiovascular patients with cardiovascular medical device products that truly address clinical pain points.
Our Programs List
We Help You Grow With Every Project Available
MITRASSIST
Cardiac Surgery
MITRASSIST
Cardiovascular Medicine
MITRASSIST
ICU, CCU, ER
MITRASSIST
Nephrology
Latest News
Read All The Information You Need
MITRASSIST LIFESCIENCES LIMITED is patient-centered and driven by technological innovation, and is committed to providing global cardiovascular patients with cardiovascular medical device products that truly address clinical pain points.
MitrAssist at TCT Conference 2024-
MitrAssist at TCT Conference 2024
2024-11-05
Recently, our team participated in TCT (The 36th Annual Transcatheter Cardiovascular Therapeutics Conference). At TCT, the organizer reported on our polymer TAVR, which was selected as the biggest cardiovascular tech stories from TCT 2024. Featured C...
The guideline included | ReDS™ Pro is included in the Russian Heart Failure Clinical Guideline 2025-
The guideline included | ReDS™ Pro is included in the Russian Heart Failure Clinical Guideline 2025
2024-10-17
The Russian Heart Failure Clinical Guideline has been officially signed by the Ministry of Health and approved to take effect from January 1, 2025. Our ReDS products have been officially included in the guidelines.
【August 21-23 | Suzhou】Mitrassist sincerely invites you to participate | Medical Fair China - Medical Device Innovation Exhibition-
【August 21-23 | Suzhou】Mitrassist sincerely invites you to participate | Medical Fair China - Medical Device Innovation Exhibition
2024-08-14
The 2024 International Medical Device Exhibition Medica Fair China will be held at Suzhou International Expo Center (No. 688, Suzhou Avenue East, Wuzhong District, Suzhou City, Jiangsu Province, China) from August 21 to 23, 2024.
Guideline included | ReDS™ Pro is included in the China National Heart Failure Guideline 2023-
Guideline included | ReDS™ Pro is included in the China National Heart Failure Guideline 2023
2024-07-24
ReDS™ Pro(non-invasive lung fluid monitor), a global new heart failure management device from Mitrassist is now included in the " China National Heart Failure Guideline 2023". (Guideline link: https://rs.yiigle.com/cmaid/1491799)

Contact Us

Ready to start a project?

Let's talk about it

*Name
*Email
Company
Address
*Message